van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier P-J; Kaye S; Degenhardt L; Skutle A; Franck J; Bu E-T; Moggi F; Dom G; Verspreet S; Demetrovics, Zsolt; Kapitány-Fövény, Máté; Fatséas M; Auriacombe M; Schillinger A; Møller M; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta, Csaba; Alleman P; Levin FR; van den Brink W; IASP Research Group
(2014)
Background: Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) in substance use disorder (SUD) patients, ranging from 2 to 83%. A better understanding of the possible ...